Home › Trial NCT00072085
Immunization With gp100 Protein Vaccine in Treating Patients With Metastatic Melanoma
- Trial IDNCT00072085
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorNational Cancer Institute (NCI)
- Enrollment—
- Start date2003-09
- ConditionsMelanoma (Skin)
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.